Home/InterShunt/Harlee Sorkin

HS

Harlee Sorkin

CEO

Therapeutic Areas

Cardiovascular Heart Failure

InterShunt Pipeline

Drug	Indication	Phase
Percutaneous Atrial Shunt Catheter System (PAS-C)	Symptomatic Heart Failure (with elevated left atrial pressure)	Pre-clinical

Leadership Team at InterShunt

VP Clinical Development

VP Clinical & Regulatory Affairs

Eugene Chung, MD

View full InterShunt profile